Quant Mutual Fund decreased its stake in SMS Pharmaceuticals from 2.96% to 2.81%, selling 135,343 shares. The transaction value is approximately ₹5.51 Cr at a share price of ₹407.05.
A diversified and integrated pharmaceutical company specializing in the manufacture and supply of Active Pharmaceutical Ingredients and pharmaceutical intermediates. SMS Pharma serves generic drug manufacturers and innovator pharmaceutical companies across domestic and international markets. The company operates integrated manufacturing facilities equipped with advanced capabilities in chemical synthesis, process development, and custom manufacturing services for its global clientele.
Built a quantitative, data-driven investment philosophy in an industry dominated by discretionary stock pickers. Manages over Rs 1.2 lakh crore. Founded by Sanjeev Sharma, Quant MF uses VLRT (Valuation, Liquidity, Risk, and Time) framework to run high-turnover, tactically active portfolios. Grew from obscurity to one of India's top-15 AMCs in under five years, attracting both retail capital and scrutiny for its aggressive churn.
